Genetic analysis of Factor XII and bradykinin catabolic enzymes in a family with estrogen-dependent inherited angioedema.
暂无分享,去创建一个
[1] M. López-Trascasa,et al. Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P. , 2008, The Journal of allergy and clinical immunology.
[2] S. Cichon,et al. Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. , 2006, American journal of human genetics.
[3] Q. Duan,et al. Kinin-dependent hypersensitivity reactions in hemodialysis: metabolic and genetic factors. , 2006, Kidney international.
[4] K. Bork,et al. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. , 2006, Biochemical and biophysical research communications.
[5] M. Rafii,et al. Orolingual angioedema associated with ACE inhibitor use after rtPA treatment of acute stroke , 2005, Neurology.
[6] J. Rouleau,et al. A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. , 2005, American journal of human genetics.
[7] J. Strong,et al. ACE insert/delete polymorphism and atherosclerosis. , 2005, Atherosclerosis.
[8] A. Tordai,et al. Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond , 2004, Journal of Allergy and Clinical Immunology.
[9] Y. Ikeda,et al. Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion , 2004, Human Genetics.
[10] M. Whitehead,et al. Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers , 2004, British journal of haematology.
[11] K. Binkley,et al. Estrogen-dependent inherited angioedema. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[12] A. Davis. The pathogenesis of hereditary angioedema. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[13] Laurence Klotz. Reactions , 2002, The Lancet.
[14] M. Cicardi,et al. Bradykinin-mediated angioedema. , 2002, The New England journal of medicine.
[15] M. Kurabayashi,et al. Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women , 2001, Menopause.
[16] J. Rouleau,et al. Bradykinin metabolism and hypotensive transfusion reactions , 2001, Transfusion.
[17] K. Bork,et al. Hereditary angioedema and normal C1-inhibitor activity in women , 2000, The Lancet.
[18] K. Binkley,et al. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. , 2000, The Journal of allergy and clinical immunology.
[19] J. Morrow,et al. Metabolism of bradykinin In vivo in humans: identification of BK1-5 as a stable plasma peptide metabolite. , 2000, The Journal of pharmacology and experimental therapeutics.
[20] T. Kanda,et al. Hormone replacement therapy in postmenopausal women with essential hypertension increases circulating plasma levels of bradykinin. , 1999 .
[21] J. Rouleau,et al. Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. , 1999, Immunopharmacology.
[22] M. Cicardi,et al. Idiopathic nonhistaminergic angioedema. , 1999, The American journal of medicine.
[23] P. Thibault,et al. Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P , 1999, Peptides.
[24] B. Stricker,et al. ACE Inhibitor-Induced Angioedema , 1998, Drug safety.
[25] A. Sacchi,et al. Molecular basis of estrogen regulation of Hageman factor XII gene expression. , 1995, Endocrinology.
[26] K. Bhoola,et al. Bioregulation of kinins: kallikreins, kininogens, and kininases. , 1992, Pharmacological reviews.
[27] P Corvol,et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.
[28] B. O’Malley,et al. Specific binding of estrogen receptor to the estrogen response element , 1989, Molecular and cellular biology.
[29] R. Champion,et al. URTICARIA AND ANGIO‐OEDEMA , 1969, The British journal of dermatology.
[30] M. Kurabayashi,et al. Effects of hormone replacement therapy on serum angiotensin-converting enzyme activity and plasma bradykinin in postmenopausal women according to angiotensin-converting enzyme-genotype. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.
[31] D. Proud,et al. Kinin formation: mechanisms and role in inflammatory disorders. , 1988, Annual review of immunology.
[32] A. Davis. C1 inhibitor and hereditary angioneurotic edema. , 1988, Annual review of immunology.